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Abstract
The commitment of multi-potent cortical progenitors to a neuronal fate depends on the transient induction of the basic-
helix-loop-helix (bHLH) family of transcription factors including Neurogenin 1 (Neurog1). Previous studies have focused on
mechanisms that control the expression of these proteins while little is known about whether their pro-neural activities can
be regulated by kinase signaling pathways. Using primary cultures and ex vivo slice cultures, here we report that both the
transcriptional and pro-neural activities of Neurog1 are regulated by extracellular signal-regulated kinase (ERK) 5 signaling in
cortical progenitors. Activation of ERK5 potentiated, while blocking ERK5 inhibited Neurog1-induced neurogenesis.
Furthermore, endogenous ERK5 activity was required for Neurog1-initiated transcription. Interestingly, ERK5 activation was
sufficient to induce Neurog1 phosphorylation and ERK5 directly phosphorylated Neurog1 in vitro. We identified S179/S208
as putative ERK5 phosphorylation sites in Neurog1. Mutations of S179/S208 to alanines inhibited the transcriptional and
pro-neural activities of Neurog1. Our data identify ERK5 phosphorylation of Neurog1 as a novel mechanism regulating
neuronal fate commitment of cortical progenitors.
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Introduction
During mammalian cortical neurogenesis, neuronal cell fate
specification is dependent on the temporal and spatial expression
of the bHLH family of transcription factors including Neurog1,
Neurogenin 2 (Neurog2), and Ascl1 (Mash1) [1–10]. These
transcription factors specify neuronal phenotype at the expense
of glial fate and subsequent choice of sub-neuronal phenotypes
during cortical development (glutamatergic vs. GABAergic). For
example, although there may be a high degree of redundancy
between Neurog1 and Neurog2 [11,12], both are expressed in the
dorsal telencephalon and direct multi-potent cortical progenitors
to a pyramidal, glutamatergic neuron fate. Ascl1 directs cortical
progenitors to a GABAergic neuron fate [9], and its expression is
high in the ventral telencephalon but low in the dorsal
telencephalon [12–14]. The pro-neural Neurog1 and Neurog2
induce the expression of NeuroD1, NeuroD2, and Nex, members
of the NeuroD family of bHLH transcription factors, which induce
terminal differentiation of the committed precursors into mature
neurons.
It has been postulated that in addition to the intrinsic molecular
properties of these bHLH transcription factors, extracellular
factors present in the microenvironment may also influence the
cell fate choice of progenitors [15–17]. Thus, it is conceivable that,
in addition to the intrinsic induction of expression of Neurog1/
Neurog2/Ascl1 proteins, extrinsic factors could activate protein
kinase signaling pathways and modulate the pro-neural activity of
Neurog1/Neurog2/Ascl1 via protein phosphorylation. However,
most research so far has focused on understanding the transcrip-
tional regulation of these bHLH transcription factors; there is
currently limited evidence that their transcriptional activities or
their ability to specify neuronal commitment are regulated post-
translationally.
We recently reported that the ERK5 (Mapk7), a member of the
mitogen-activated protein (MAP) kinase family, provides an
instructive signal to specify cortical progenitors to a neuronal fate
[18]. In this study, we tested the hypothesis that the pro-neural
activity of Neurog1 may be regulated by ERK5 during cortical
neurogenesis.
Results
Activation of ERK5 potentiates while inhibition of ERK5
attenuates Neurog1-stimulated neurogenesis
Our previous studies established that ERK5 is necessary and
sufficient to promote neuron fate specification of cortical
progenitors [18]. Because ERK5 is a MAP kinase that can
phosphorylate and regulate the activity of several transcription
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a neuronal fate, we postulated that the pro-neural activity of
ERK5 may be due to ERK5 regulation of Neurog1. To test this
hypothesis, we performed a neurosphere assay to determine if
ERK5 regulates Neurog1-stimulated neurogenesis in vitro (Fig. 1).
Freshly dissociated embryonic day (E) 13 rat cortical progenitor
cells were infected with lentiviral stocks encoding Neurog1, wild-
type (wt) ERK5, constitutive active (ca) or dominant negative (dn)
MEK5, an upstream kinase of ERK5. These genes were coupled
to GFP through an internal ribosomal entry site (IRES) so that
virus-infected cells can be easily identified by GFP expression [18].
Lentiviral infection was carried out 3 h after initial plating when
the cells were still at the single-cell level in suspension. Neurons
were identified by immunostaining of b-III tubulin, a marker
expressed in immature neurons (Fig. 1 A). Those neurospheres
with less than 10 b-III tubulin
+ cells were defined as non-neuron
spheres. Quantification of the data demonstrated that ectopic
expression of Neurog1 significantly reduced the total number of
non-neuron spheres compared to control GFP-infected spheres
(Neurog1 15%; GFP 73%) (Fig. 1 B). This is consistent with other
reports that ectopic expression of Neurog1 is sufficient to induce
neurogenesis [6,7]. Similar results were obtained with ectopic
ERK5 activation (caMEK5+wtERK5), consistent with our
previous report [18]. Co-expression of Neurog1 with caMEK5+w-
tERK5 generated no non-neuron spheres. Furthermore, the
neurogenic effect of Neurog1 was reversed by co-expression of
dnMEK5 which blocks ERK5 activation.
We next performed a more detailed analysis to examine the
effect of ERK5 on Neurog1-induced neurogenesis by scoring the
percentage of neurons within each neurosphere. In control GFP
virus-infected neurospheres, the majority of the neurospheres
contained #10% b-III tubulin
+ neurons in each sphere (Fig. 1
C). Expression of lentiviral Neurog1 greatly increased the number
of neurospheres with a higher percentage of neurons. Activation of
ERK5 signaling (caMEK5+wtERK5) also increased the number
of neurospheres with a higher percentage of neurons. Significantly,
ERK5 activation potentiated Neurog1-induced neurogenesis. In
contrast, Neurog1-induced neurogenesis was completely blocked
by inhibiting ERK5 signaling with dnMEK5 (Fig. 1 D).I n
addition to the neurosphere-forming assay, we utilized a
progenitor cell clonal assay under adherent culture conditions
[18] to examine the effect of ERK5 on Neurog1 at the single
progenitor cell level (Fig. 1 E). Expression of dnMEK5 or
dnERK5 blocked cortical neurogenesis stimulated by Neurog1 in
this clonal assay (Fig. 1 F). These data provide evidence that the
ERK5 signaling pathway regulates the pro-neural activity of
Neurog1.
ERK5 signaling regulates Neurog1-initated gene
expression
Since Neurog1 induces neuronal cell fate specification and
differentiation primarily through the transactivation of neuron-
specific genes, we investigated if ERK5 regulates the transcrip-
tional activity of Neurog1. Using a NucleofectorH method, we
transiently transfected freshly isolated, rat E13 cortical progenitor
cells with a Flag-Neurog1 expression vector and dnMEK5 as
indicated (Fig. 2). Cells were co-transfected with a luciferase
reporter construct driven by a Neurog1-reponsive, 3-tandem
repeats of the putative E-box DNA binding site (CAGATG) (3xE-
box-Luc). Ectopic expression of Neurog1 increased transcription
initiated from the 3xE-box-Luc; this induction was significantly
inhibited by co-expression of dnMEK5 (Fig. 2 A). These data
suggest that interfering with ERK5 signaling can disrupt gene
transcription initiated by Neurog1.
Does ERK5 signaling modulate the activities of endogenous
bHLH transcription factors? Although Neurog1, Neurog2, and
Ascl1 are capable of binding and activating the E-box and native
NeuroD2 promoter [6,19], Ascl1 expression is extremely low in
dorsal telencephalon [12]. Therefore, Neurog1 and Neurog2 are
most likely the main endogenous transcription factors capable of
stimulating the E-box-Luc or NeuroD2 promoter-driven reporters
in cortical progenitor preparations isolated from E13 rat dorsal
telencephalon. We transiently transfected E13 cortical progenitors
with the 3xE-box-Luc or a NeuroD2 promoter-driven luciferase
(NeuroD2-Luc) without introducing exogenous Neurog1 to
monitor the activity of endogenous bHLH transcription factors.
Cells were co-transfected with dnMEK5 to block ERK5 signaling
or the cloning vector as a control. Inhibition of ERK5 signaling
significantly reduced transcription of both reporters initiated by
endogenous bHLH transcription factors present in rat E13 cortical
cells (Fig. 2, B and C). Together, data in Figure 2 suggest that
ERK5 regulates the transcriptional activity of Neurog1.
ERK5 regulation of Neurog1 transcriptional activity may
be mediated through phosphorylation
Because ERK5 is a MAP kinase that can directly phosphorylate
and regulate the activity of transcription factors [20], we
postulated that ERK5 may regulate the transcriptional activity
of Neurog1 through direct phosphorylation. A protein sequence
analysis revealed two perfectly matched, putative proline-directed
MAP kinase phosphorylation sites (PX 1-2 S/T P), S179 and S208,
and two imperfect sites (S/T P), S201 and T237, within the C-
terminus of Neurog1 (Fig. 3 A). Although mutations of S201 or
T237 to non-phosphorylatable alanines had no effect on
Neurog1’s transcriptional activity (Fig. 3 B), replacing S179 or
S208 with alanines almost completely abolished Neurog1’s ability
to initiate transcription in HEK293 cells (Fig. 3 C) and in cortical
neurons (Fig. 3 F). The distinct effects of the four mutations on
Neurog1’s transcriptional activity were not due to differential
expression of the mutant proteins (Fig. 3, D and E). These
results suggest that Neurog1’s transcriptional activity requires the
function of S179 and S208. Furthermore, phosphorylation of S179
and S208 may regulate the transcriptional activity of Neurog1.
Because the double mutant SA179/208 was as effective as, if not
more potent than, the single mutants we focused our efforts on the
double mutant for the remaining investigation.
We investigated if activation of ERK5 induces Neurog1
phosphorylation. When Flag-Neurog1 was expressed alone in
HEK293 cells or when co-transfected with dnERK5 as a control,
it appeared as multiple bands on a 12% SDS gel, running at
approximately 37 kDa (Fig. 4 A). However, when co-transfected
with caMEK5+wtERK5 to activate ERK5 signaling in transfected
cells, the majority of the Flag-Neurog1 exhibited reduced
electrophoretic mobility suggesting that Neurog1 is phosphorylat-
ed in cells when ERK5 is activated. Indeed, the reduced
electrophoretic mobility of Neurog1 was abolished when whole
cell lysates were treated with calf intestine alkaline phosphatase
(CIP) (Fig. 4 B), confirming that the gel shift is due to
phosphorylation of Neurog1. In contrast, ERK5 activation did
not reduce the electrophoretic mobility of the mutant SA179/208
Neurog1 (Fig. 4 C). Thus, activation of ERK5 signaling leads to
wt, but not the mutant SA179/208 Neurog1 phosphorylation in
HEK293 cells.
To determine if ERK5 directly phosphorylates Neurog1, active
ERK5 was immunoprecipitated using an anti-Flag antibody from
HEK293 cells transfected with HA-tagged caMEK5 and Flag-
tagged wtERK5. The immunoprecipitated ERK5 was incubated
with
32P-ATP and purified recombinant GST-Neurog1 (151–244)
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PLoS ONE | www.plosone.org 2 April 2009 | Volume 4 | Issue 4 | e5204Figure 1. Activation of ERK5 potentiates while inhibition of ERK5 attenuates Neurog1-stimulated neurogenesis. For panels A–D,
neurosphere assays. Freshly dissociated E13 cortical progenitors were co-infected with lentiviruses encoding Neurog1, constitutive active (ca) or
dominant negative (dn) MEK5, or wild-type ERK5 as indicated. Cells infected with GFP-virus were used as a control. Neurospheres were allowed to
form in culture for 5 d, and then transferred to PDL/laminin coated plates in bFGF-free medium to promote spontaneous differentiation for 3 d.
Neurospheres infected with lentiviruses were identified by GFP expression. Neurons were identified by the pan-neuronal marker, b-III tubulin. A,
Representative images of neurospheres infected with either GFP control virus (control) or wild-type Neurog1, and immunostained for b-III tubulin
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HEK293 cells were also co-transfected with HA-tagged dnMEK5
and Flag-tagged wtERK5 as a control for the active ERK5. The
kinase activity of ERK5 was monitored by its autophosphorylation
(
32P-ERK5) (Fig. 4 E). The wild-type GST-Neurog1 (151–244)
was robustly phosphorylated by active ERK5 but not by the
control inactive ERK5 (Fig. 4, E and F). Importantly, active
ERK5 did not significantly phosphorylate the GST-Neurog1
SA179/208 mutant protein (Fig. 4, E and F). These data suggest
that ERK5 directly phosphorylates Neurog1 on S179, S208, or
both.
To investigate if Neurog1 phosphorylation occurs in rat E13
cortical progenitors, freshly dissociated E13 rat cortical cells were
infected with lentiviral stocks encoding GFP control or wt
Neurog1. Cell lysates were collected 3 d later and treated with
CIP (Fig. 4 G). Treatment with CIP reduced the electrophoretic
mobility of Neurog1, indicating that Neurog1 expressed in E13
cortical progenitor cells exists as a phosphorylated protein.
Similarly, Neurog1 was phosphorylated when expressed ex vivo in
rat E15 cortex slices (Fig. 4 H).
Phosphorylation of Neurog1 at S179 and S208 regulates
the pro-neural activity of Neurog1
To examine if phosphorylation on S179 and S208 modulates
the pro-neural activity of Neurog1, we infected LeX
+-enriched rat
E13 cortical progenitors with lentiviruses encoding Flag-tagged, wt
Neurog1, Flag-Neurog1 SA179/208, dnMEK5, caMEK5 togeth-
er with wtERK5, or a combination of these constructs as indicated
(Fig. 5). Lentiviral GFP was used as a control. All of the viral
expression vectors were coupled to GFP through IRES and virus-
infected cells were identified by anti-GFP immunostaining (green)
(Fig. 5 A). Cortical progenitors were identified by nestin
immunostaining (red). Virus-infected cells that express nestin
stained orange in merged images. Quantification of the data
demonstrated that ectopic expression of Neurog1 decreased the
number of cells co-labeled with nestin (Fig. 5 B), suggesting that
Neurog1 decreases the pool of cortical progenitors in the infected
cell population.
Neuronal differentiation was assessed by immunostaining with
b-III tubulin and the mature neuron marker, MAP-2 (Fig. 6, A
and B). In contrast to the nestin staining, ectopic expression of
Neurog1 increased the number of GFP
+ cells co-labeled with b-III
tubulin (Fig. 6 C) or MAP-2 (Fig. 6 D). The concomitant
decrease in nestin expression and increase in b-III tubulin and
MAP-2 expression suggest a pro-neural effect of Neurog1.
Importantly, the pro-neural effect of Neurog1 was greatly
attenuated by co-expression of dnMEK5 (Fig. 5 B and Fig. 6,
C and D), consistent with the data in Figure 1. Significantly,
mutations of S179 and S208 to alanines greatly reduced the
neurogenic activity of Neurog1. Furthermore, expression of the
SA179/208 mutant Neurog1 attenuated the neurogenic activity
afforded by ERK5 activation (caMEK5+wtERK5). These data
suggest that the pro-neural effect of Neurog1 is regulated by
ERK5 phosphorylation and that Neurog1 is a downstream
mediator of ERK5’s effect on neuronal fate specification.
We utilized ex vivo electroporation coupled to organotypic slice
culture to examine the effect of SA179/208 mutations on
Neurog1’s pro-neural activity. The organotypic slice cultures
maintain some of the anatomy and cell-cell interactions of the
intact cortex [21]. Plasmid DNA encoding vector control, wt
Neurog1 and the Neurog1 SA179/208 mutant were injected into
the lateral ventricles of dissected E15 rat brains. A GFP plasmid
was co-injected as a marker to identify transfected cells. The
electrodes were placed in a way to consistently favor plasmid DNA
electroporation into the dorsolateral cortex. The cortices were
sliced into 300 mm sections and cultured ex vivo. The cellular
Figure 2. ERK5 signaling is required for transcription initiated by ectopically expressed Neurog1 and endogenous bHLH
transcription factors in E13 cortical progenitors. Rat E13 cortical progenitor cells were transiently transfected with a control vector (vector),
Neurog1, and dnMEK5 as indicated. The transcriptional activity of Neurog1 was monitored using a co-transfected 3xE-Box-Luc or a NeuroD2-Luc
reporter. Luciferase activity was normalized to a co-transfected LacZ reporter. A, Expression of wt Neurog1 stimulates 3xE-box luciferase activity,
which was inhibited by dnMEK5. B, Expression of dnMEK5 inhibits 3xE-box luciferase activity afforded by endogenous bHLH transcription factors. C,
NeuroD2-luciferase activity induced by endogenous bHLH transcription factors is inhibited by dnMEK5.
doi:10.1371/journal.pone.0005204.g002
(red) and GFP (green). B, Effect of Neurog1 and ERK5 on the percentage of non-neuron spheres, defined as those neurospheres containing #10%
neurons per sphere. C, Activation of ERK5 signaling potentiates the neurogenic effect of Neurog1. Data show distribution of the percentage of
neurons per neurosphere. Data were collected from three independent experiments (n=3). D, Inhibition of ERK5 signaling by dnMEK5 abolishes the
neurogenic effect of Neurog1. E, Representative images of a progenitor cell clone in an adherent culture clonal assay, which allows us to specifically
follow the cell fate of a single LeX
+ cortical progenitor cell (Liu et al., 2006). Progenitor cells infected with lentiviruses were identified by GFP
expression. Cells were immunostained for GFP (green) and b-III tubulin (red). F, Expression of dnMEK5 or dnERK5 suppresses the pro-neural effect of
Neurog1 using the adherent culture clonal assay.
doi:10.1371/journal.pone.0005204.g001
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PLoS ONE | www.plosone.org 4 April 2009 | Volume 4 | Issue 4 | e5204Figure 3. S179 and S208 are required for Neurog1’s transcriptional activity. A, Schematic representation of the various functional domains
of Neurog1. Four putative proline-directed MAP kinase phosphorylation sites (PX1-2S/TP), S179, S201, S208 and T237 are present within the presumed
transactivation domain in the C-terminus. B, Replacing S201 or T237 with alanine had no effect on Neurog1’s ability to stimulate NeuroD2-luciferase
in HEK293 cells. V: vector control. C, Replacing S179, S208, or both with alanine almost completely abolished Neurog1’s ability to stimulate NeuroD2-
luciferase in HEK293 cells. D, E, Western analysis demonstrating equal expression of wt Neurog1 and Neurog1 mutants in HEK293 cells. F, Replacing
S179, S208, or both with alanine greatly attenuates Neurog1’s ability to stimulate NeuroD2-luciferase activity in E16 cortical neuron cultures.
doi:10.1371/journal.pone.0005204.g003
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PLoS ONE | www.plosone.org 5 April 2009 | Volume 4 | Issue 4 | e5204Figure 4. Activation of ERK5 is sufficient to induce Neurog1 phosphorylation. A, ERK5 activation in HEK293 cells leads to an electrophoretic
mobility shift of Neurog1, indicative of Neurog1 phosphorylation (p-Neurog1). HEK293 cells were transiently transfected with either vector control (V)
or Flag-Neurog1. Cells were also co-transfected with HA-tagged caMEK5 and Flag-wtERK5 to activate ERK5 signaling in transfected cells. Cells co-
transfected with Flag-dnERK5 were used as a control. Cell lysates were analyzed by anti-Flag Western blotting. B, The electrophoretic mobility shift of
Neurog1 was abolished after treatment with CIP. C, ERK5 activation does not induce an electrophoretic mobility shift of the mutant SA179/208
ERK5 Regulation of Neurogenin1
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+) was identified by
immunostaining for PCNA (Fig. 7 A), a marker for cells in early
G1/S phase, or the T-box brain (Tbr) 2 (Fig. 7 B), a transcription
factor and marker for cells actively proliferating in the upper layer
of the ventricular zone (VZ) and the sub-ventricular zone (SVZ)
[22,23]. The slices were also stained with Tbr1 (Fig. 8 A) or
NeuN (Fig. 8 B), markers for post-mitotic neurons in the cortical
plate during development [22,24,25] and mature neurons,
respectively. Co-labeling of cells immunopositive for GFP and
PCNA (Fig. 7 C), Tbr2 (Fig. 7 D), Tbr1 (Fig. 8 C), or NeuN
(Fig. 8 D) was confirmed using de-convolution imaging under
high magnification.
In control, vector-transfected cells, most of the transfected cells
(GFP
+) were still proliferating (47% PCNA
+ or 66% Tbr2
+)
Figure 5. Wild type, but not SA179/208 mutant Neurog1 reduces the pool of nestin
+ cortical progenitors in monolayer cortical
progenitor cultures. Freshly dissociated, LeX
+-sorted E13 rat cortical progenitors were plated on PDL/laminin-coated plates and immediately
infected with various lentiviral stocks encoding genes of interest-IRES-GFP as indicated. Cells were grown for 2 d in bFGF containing medium, and
then in bFGF-free medium for another 2 d to allow differentiation. A, Representative deconvolution images of cells infected with either GFP control
virus or wt Neurog1, and stained for nestin (red). GFP immunostaining (green) labels virus-infected cells. Hoechst (blue) staining labels nuclei. Cells
that were co-labeled with GFP and nestin were orange. Images were captured using 406objective lens. Scale bar: 25 mm. B, Quantification of the
data showing percentage of nestin
+ precursors in GFP
+ population. Three independent experiments were done, each in triplicate and .2000 GFP
+
cells were counted for each data point.
doi:10.1371/journal.pone.0005204.g005
Neurog1. D, Schematic drawings of GST-Neurog1 fusion proteins in which the putative transactivation domains of the wt or SA179/208 mutant
Neurog1 (a.a. 151–244) were fused with GST. E, Activated ERK5 can directly phosphorylate recombinant wt GST-Neurog1 but not the mutant GST-
Neurog1 SA179/208 in vitro. Active ERK5 was immunoprecipitated using an anti-Flag antibody from HEK293 cells co-transfected with HA-tagged
caMEK5 and Flag-tagged wtERK5. Cells co-transfected with dnMEK5 and wtERK5 were used as a control. The ability of ERK5 to directly phosphorylate
Neurog1 (
32P-GST-Neurog1) was measured by an in vitro kinase assay using recombinant GST-Neurog1 fusion proteins and
32P-ATP as substrates.
ERK5 autophosphorylation (
32P-ERK5) confirms the relative activity of ERK5. Western blotting for Neurog1 or GST was used to confirm comparable
loading of the recombinant Neurog1 protein in the kinase assay. F, Quantification of data in panel E. Relative Neurog1 phosphorylation was
normalized to Neurog1 protein levels based on anti-Neurog1 Western blotting. G, Ectopically expressed Neurog1 is phosphorylated in cultured rat
E13 cortical progenitors. E13 cortical progenitor cultures were infected with lentiviral Neurog1 and maintained in bFGF-containing medium for 3 d. H,
Ectopically expressed Neurog1 is phosphorylated in rat E15 ex vivo cortical slice cultures. Plasmid DNA encoding control vector or wt Flag-Neurog1
was electroporated ex vivo into the dorsolateral telencephalon of rat E15 brain. A GFP expression vector was co-electroporated to identify transfected
region. Cortical slices were sectioned coronally and cultured for 40–50 h. GFP
+ regions were excised out under a fluorescent microscope for Western
analysis. To increase the yield of Neurog1 protein expression, a cocktail of proteasomal inhibitors and pan-caspase inhibitors were added to cultured
cells or slices 6 h before harvesting in panels A–C, G, and H.
doi:10.1371/journal.pone.0005204.g004
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fraction of the cells had differentiated (8% Tbr1
+ or 14% NeuN
+)
(Fig. 8, E and F) and migrated to the cortical plate (CP) after
40 h in culture. However, more of the wt Neurog1-transfected
cells were found in the CP layer and were Tbr1
+ (37%) or NeuN
+
(45%). This supports our in vitro cell culture data shown in Fig. 1, 5,
and 6 and demonstrates a role for Neurog1 in promoting
neurogenesis in slice cultures. In contrast, cells transfected with
the Neurog1 SA179/208 mutant behaved like vector control-
transfected cells; most remained proliferative (54% PCNA
+, 68%
Tbr2
+) and only a few expressed the post-mitotic neuron markers
Tbr1 (12%) or NeuN (18%). Because the Neurog1 SA179/208-
transfected cells found in the SVZ/VZ expressed PCNA and layer
specific marker Tbr2 but did not express post-mitotic neuron
markers Tbr1 or NeuN, we conclude that Neurog1 phosphory-
lation at S178 and S208 does not affect neuronal migration. These
data suggest that mutations at the putative ERK5 phosphorylation
sites S179 and S208 suppress the pro-neural activity of Neurog1.
We also examined the effect of blocking ERK5 expression on
the pro-neural activity of Neurog1 using the organotypic slice
culture assay. To block expression of endogenous ERK5, we
constructed a retroviral shRNA vector against ERK5. A non-
specific shRNA against dsRed (NS) was used as a control. Specific
knockdown of ERK5 expression by shERK5 was confirmed in
cultured rat E13 cortical progenitors (Fig. S1). Cells co-
transfected with Neurog1 and shERK5 had greatly increased
numbers of proliferative PCNA
+ or Tbr2
+ cells (Fig. 7, G and H)
and fewer differentiated Tbr1
+ or NeuN
+ neurons (Fig. 8, G and
H) compared to those co-transfected with Neurog1 and NS
control. These data suggest that blocking ERK5 expression and
signaling attenuates the pro-neural effect of Neurog1 in cortical
slice cultures.
Discussion
The objective of this study was to investigate downstream
mechanisms mediating the neurogenic activity of ERK5. We
published evidence that ERK5 is highly expressed in proliferating
cortical progenitor cells and is both necessary and sufficient to
specify cortical progenitor cells towards a neuronal fate [18]. We
report here that Neurog1 is a downstream target of ERK5. ERK5
directly phosphorylated Neurog1 in vitro and modulated the
transcriptional and pro-neural activity of Neurog1 in cortical
progenitors. We also identified S179 and S208 as putative ERK5
phosphorylation sites on Neurog1. These two serine residues are
located within the putative transactivation domain of Neurog1
[26]. Intact S179 and S208 were required for Neurog1’s function
since replacing each with a non-phosphorylatable alanine greatly
attenuated the ability of Neurog1 to initiate transcription and
specify neuronal fate. These data identify Neurog1 as a
downstream target mediating the pro-neural effect of ERK5 and
implicate phosphorylation of Neurog1 as a novel mechanism
regulating neuronal fate commitment of cortical progenitors.
During cortical neurogenesis, the pro-neural bHLH transcrip-
tion factors including Neurog1, Neurog2, and Ascl1 direct cortical
progenitors to a neuronal fate [9]. Many signaling pathways have
been implicated in stimulating neuronal differentiation including
the Wnt/b-catenin pathway [27], PI3K [28], Notch pathway
[15,29,30], and the ERK1/2 pathway [31,32]. However, it is not
known if these signaling pathways regulate the pro-neural activity
of the bHLH transcription factors. Protein phosphorylation has
been implicated in regulating the stability and function of bHLH
transcription factors during neuronal terminal differentiation,
maturation and sub-neuronal phenotype specification. For exam-
ple, Neurog1 stability is regulated by protein phosphorylation and
subsequent ubiquitin-mediated proteolysis [33]. The function of
Xenopus NeuroD in retinal neuron differentiation is inhibited by
glycogen synthase kinase (GSK) 3b, presumably via GSK3b
phosphorylation of XNeuroD [34]. CaMK II induces the
phosphorylation of NeuroD at Ser 336, which regulates granule
neuron dendritic morphogenesis during cerebellar development
[35]. In addition to their pro-neural activity, Neurog1 and
Neurog2 also regulate neuron migration [36,37], and a recent
report implicates phosphorylation of Neurog2 in the regulation of
neuron migration [37]. Another recent report demonstrates that
Neurog2 phosphorylation at Ser231 and Ser234 by GSK3
regulates the specification of motor neuron subtypes but has no
effect on the total number of neurons produced per se [38]. There is
little published data addressing the role of kinases or phosphor-
ylation in modulating the production of neurons which can be
attributed to the function of Neurog1, Neurog2, or Ascl1. Our
study is the first to demonstrate that phosphorylation of Neurog1
modulates the total number of neurons produced from cortical
progenitors.
The putative ERK5 phosphorylation sites S179 and S208 are
evolutionarily conserved among mouse, rat, and human sequences
of Neurog1 (Fig. S2). A putative phosphorylation site similar to
S208 is also found in the Neurog1 sequence of non-mammalian
vertebrates zebrafish and xenopus. Furthermore, two putative
phosphorylation sites comparable to S179 and S208 exist in the
Neurog2 sequence (Fig. S3). Therefore, protein phosphorylation
of the pro-neural bHLH transcription factors may be a common
mechanism by which extrinsic factors in the neurogenic niche
regulate the neuronal fate specification of neural progenitor cells.
A large body of evidence suggests that environmental cues such
as the microenvironment surrounding progenitor cells play an
important role in cell fate determination of neural progenitor cells
[16,17,39–42]. Since ERK5 is activated by neurotransmitters,
growth factors, and neurotrophins including NT3/4 and BDNF
[43,44], it seems likely that environmental cues may instruct
cortical progenitors to become neurons by activating the ERK5-
Neurog1 pathway.
Interestingly, the Neurog1-NeuroD axis bears significant
similarity to the myogenic MyoD-Myogenin pathway of muscle
differentiation [45]. There is evidence that the myogenic bHLHs,
MyoD and Myogenin, are phosphoproteins [46,47] and that
MyoD and Myogenin can be directly phosphorylated by ERK5
[48]. Besides its high level of expression in the nervous system,
ERK5 is also highly expressed in muscle and is required for muscle
differentiation [48]. Thus, phosphorylation of the bHLH tran-
scription factors may be a conserved mechanism by which ERK5
regulates muscle and neuron differentiation. Neurog1 also confers
Figure 6. Neurog1-induced neurogenesis is regulated by phosphorylation on S179 and S208 in monolayer cortical progenitor
cultures. Cells were cultured as in Figure 5. A, B, Representative deconvolution images of cells infected with either GFP control virus or wt Neurog1,
and immunostained for b-III tubulin (A) or MAP-2 (B) (red). Cells that were co-labeled with GFP and b-III tubulin, or MAP-2 were orange. Images were
captured using 406objective lens. Scale bar: 25 mm. C, D, Quantification of the data showing percentage of b-III tubulin
+ neurons (C), or MAP-2
+
mature neurons (D), in GFP
+ population. Three independent experiments were done, each in triplicate and .2000 GFP
+ cells were counted for each
data point.
doi:10.1371/journal.pone.0005204.g006
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PLoS ONE | www.plosone.org 9 April 2009 | Volume 4 | Issue 4 | e5204Figure 7. Mutations of Neurog1 at S179 and S208 and inhibition of ERK5 signaling retains Neurog1-transfected cells in
proliferating state in organotypic slice cultures. Plasmid DNA encoding control vector, wt Neurog1, SA179/208 Neurog1, shRNA against dsRed
(NS) or ERK5 (shERK5) was electroporated ex vivo into the dorsolateral telencephalon of rat E15 brain as indicated. A GFP expression vector was co-
electroporated to identify transfected cells. Cortical slices were sectioned coronally, cultured for 40 h, and cryosectioned for immunostaining. A, B,
Representative deconvolution images of cortical slices immunostained for GFP (green) and PCNA or Tbr2 (red), respectively. Images were captured
using a 206objective lens. Scale bar: 50 mm. C, D, Representative high magnification (636) images of GFP
+ cells co-labeled with PCNA or Tbr2,
respectively. E–H Quantification of cells double-immunostained for GFP and PCNA (panels E and G) or Tbr2 (panels F and H) in total GFP
+ cells. Vector:
vector control. The data were obtained from at least three sections each from three independent experiments.
doi:10.1371/journal.pone.0005204.g007
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PLoS ONE | www.plosone.org 10 April 2009 | Volume 4 | Issue 4 | e5204Figure 8. Neurog1-induced neurogenesis is suppressed by mutations at S179 and S208 and inhibition of ERK5 signaling in
organotypic slice cultures. Cortical slices were transfected and cultured as in Figure 7. A, B, Representative deconvolution images of cortical slices
immunostained for GFP (green) and Tbr1 or NeuN (red), respectively. Images were captured using a 206 objective lens. Scale bar: 50 mm. C,D,
Representative high magnification (636) images of GFP
+ cells co-labeled with Tbr1 or NeuN, respectively. E–H Quantification of cells double-
immunostained for GFP and Tbr1 (panels E and G) or NeuN (panels F and H) in total GFP
+ cells. Vector: vector control. The data were obtained from at
least three sections each from three independent experiments.
doi:10.1371/journal.pone.0005204.g008
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nervous system [7]. It would be interesting to examine if ERK5
phosphorylation also modulates the anti-gliogenic properties of
Neurog1.
A number of ERK5 substrates have been identified, including
myocyte enhancer factor (MEF) 2C, Sap 1a, c-myc, SGK (serum-
and glucocorticoid-inducible kinase), the pro-apoptotic Bcl-2
family protein BAD, and pp90Rsk [20,49–51]. ERK5 has been
implicated in many aspects of cellular and physiological function
including apoptosis, cell cycle, muscle differentiation, cardiovas-
cular function, neuronal survival, and neuronal cell fate specifi-
cation [18,50–52]. Data presented here identify Neurog1 as a new
substrate for ERK5 and implicate ERK5 in the regulation of the
pro-neural bHLH transcription factors.
In summary, we identified a novel mechanism during cortical
neurogenesis in which the pro-neural and transcriptional activity
of Neurog1 is regulated by ERK5 through phosphorylation.
Similar kinase phosphorylation mechanisms may also regulate the
pro-neural activities of other bHLH family transcription factors
including Neurog2 and Ascl1.
Materials and Methods
Reagents
The following plasmids have been described: the lentiviral
transfer vector pRRL-cPPT-CMV-X-PRE-SIN [53], a kind gift
from Dr. W. Osborne (University of Washington); NeuroD2-Luc
reporter [3]; expression vectors for dnMEK5, caMEK5, wtERK5
and dnERK5 [20]. The Neurog1 expression vector (pCS2-
NeuroD3) and the 3xE-box-Luc reporter (pCS2-EB7-Luc) were
obtained from Dr. Jim Olson [3]. The cDNA sequence of Neurog1
was sub-cloned into pcDNA3 with a Flag-tag added to its N-
terminus. For the truncated wt GST-Neurog1 and SA179/208
mutant, the cDNA sequences corresponding to residues 151–244
were subcloned into the pGEX vector. The rabbit polyclonal anti-
ERK5 antibody [43] and the polyclonal Tbr2 and Tbr1 antibodies
have been described [22]. The rabbit polyclonal anti-Neurog1
antibody was generated by immunizing rabbits (Cocalico Biolog-
icals, Reamstown, PA) with GST-Neurog1 fusion protein. The
following antibodies for immunostaining were purchased commer-
cially: mouse monoclonal(M1)anti-Flag antibody (Sigma, St.Louis,
MO); mouse monoclonal anti-nestin (Becton Dickinson, Bedford,
MA); mouse monoclonal anti-NeuN (Chemicon, Temecula, CA);
rabbitpolyclonal anti-GFP(Molecular Probes,Eugene,OR);mouse
monoclonal anti-GFP (Molecular Probes), mouse monoclonal anti-
b-III tubulin (Promega, Madison, WI); mouse monoclonal anti-
MAP-2 (Sigma); monoclonal anti-LeX (CD15 FITC) (Becton
Dickinson); mouse monoclonal anti-PCNA (Chemicon). The
following inhibitors were purchased commercially: Proteasomal
Inhibitor Cocktail Set (Calbiochem, San Diego, CA), pan-caspase
inhibitor ZVAD-FMK (R&D Systems, Minneapolis, MN).
Lentivirus constructs
We have constructed lentiviral transfer vectors as previously
described [18]. All genes of interest were N-terminal Flag-tagged
and inserted into a multiple cloning site upstream from an IRES-
directed marker protein eGFP (enhanced green fluorescent
protein).
Retrovirus constructs
The shRNA sequences against mouse ERK5 and dsRed [54]
were cloned into the BamHI/Xbal sites of the multiple cloning site
of the pSIE dual promoter retroviral vector [55]. The shRNA
expression is under the control of human U6 promoter and GFP
expression is under the control of the EF1a promter. The targeted
sequences used were as follows: ERK5 (aa 106–111) acacttcaaa-
cacgacaat; dsRed-C1 agttccagtacggctccaa.
Rat E13 cortical progenitor cell cultures
These were prepared as described and cells were maintained in
culture medium containing 10 ng/ml bFGF (Invitrogen, Inc) [18].
For the adherent culture monolayer assay or progenitor cell clonal
assay, cortical progenitors were enriched by magnetic activated
cell sorting (MACS) after labeling with an antibody against LeX
(anti-CD15), a cortical progenitor marker [56]. For the neuro-
sphere assay, freshly dissociated E13 cortical progenitor cells were
plated at a clonal density of 2000 cells/ml in petri dishes without
any coating.
Ex vivo electroporation and organotypic slice culture
Plasmid DNA was injected into the lateral ventricles of E15 rat
brain and electroporated into the cortex using a CUY21 Edit
square pulse electroporator (Bex Co. Ltd., Japan). Plasmid was
targeted to the dorsal region of the telencephalon by placing the
positive electrode directly superior to the telencephalon and the
negative electrode ventral to the head. Following electroporation,
dissected cortices were immobilized in a 4% agarose mold and
sliced into 300 mm slices using a vibrating microtome, transferred
to permeable membranes and placed in growth medium for 40–
50 h. Organotypic slice cultures were fixed and cryosectioned into
successive 20 mm slices for immunostaining. For Western analysis,
regions with GFP expression (green) were micro-dissected out
under a fluorescence microscope and homogenized with a syringe
in lysis buffer followed by vortexing to prepare cell lysates.
Luciferase reporter gene assays
Rat E13 cortical progenitor cells were transiently transfected at
days in vitro (DIV) 2 using the NucleofectorH electroporation
method per manufacturer’s instruction (Amaxa Biosystems, Inc.).
Briefly, the cells were grown as a monolayer in coated plates for 1–
2 d, trypsinized at room temperature for 5 min and centrifuged at
735g for 5 min. Cells were resuspended in Rat Neural Stem Cell
NuclofectorH Transfection Reagent (Amaxa Biosystems, Inc.) at a
density of 3610
6 cells/100 ml. For each transfection, 3610
6 cells
were transfected with total plasmid DNA not exceeding 10 mg using
theA31(lowtoxicity) protocol. Followingelectroporation,cellswere
resuspended in pre-warmed (37uC) regular culture medium and
incubated at 37uC for 20 min. Cells were then resuspended in
regular culture medium and plated onto 24-well plates coated with
laminin and poly-D-lysine (PDL). Cell lysates were prepared 36–
48 h later for reporter gene assay as described [43].
For E16 cortical neuron luciferase reporter gene assays, neurons
were prepared and transfected using LipofectAMINE 2000
(Invitrogen) as described [43,52].
Calf intestinal alkaline phosphatase treatment
Protein lysates were homogenized in protein lysis buffers lacking
phosphatase inhibitors [57]. One hundred micrograms of protein
lysates were treated with 10 units of CIP (Fermentas, Inc.) and
10 mM MgCl2 for 60 min at 37uC. For control, protein lysates
were homogenized in regular protein lysis buffers containing
phosphatase inhibitors.
In vitro kinase assays
In vitro ERK5 kinase assays were performed as described
[43,58]. Briefly, whole cell lysates (1000 mg protein) were
incubated at 4uC for 2.5 h with 6 ml of polyclonal anti-ERK5
ERK5 Regulation of Neurogenin1
PLoS ONE | www.plosone.org 12 April 2009 | Volume 4 | Issue 4 | e5204antibody. Protein A-Sepharose beads (60 ml) were then added, and
the mixture was incubated at 4uC for an additional hour. The
activity of ERK5 in the immunoprecipitates was quantified by a
kinase assay using 30 mg recombinant wt GST-Neurog1 (151–244)
or GST-Neurog1 SA179/208 (151–244) as the substrates. Relative
radiolabeled Neurog1 and ERK5 was quantified using autoradi-
ography and normalized to total wt GST-Neurog1 and GST-
Neurog1 SA179/208 protein levels.
Microscopy and image acquisition
Representative images were generated by a Marianas imaging
system (Intelligent Imaging Innovations, Inc.) incorporating a
microscope (Axiovert 200M; Carl Zeiss MicroImaging, Inc.) with
an X,Y motorized stage, shuttered 175 W xenon lamp coupled
with a liquid light guide, a digital camera (CoolSNAP HQ; Roper
Scientific), and 206 or 636 objective lens (Axiovert; Carl Zeiss
MicroImaging, Inc.) as indicated. Slidebook software package was
used for system control and image processing. Adobe Photoshop
was used to uniformly optimize images.
To capture images for quantification of organotypic slice
cultures, images were generated with an inverted fluorescence
microscope (Leitz DMIRB; Leica) using a 406 objective lens
(Leitz; Leica). MagnaFire digital microscope camera and Magna-
Fire software (Optronics, Inc.) were used for system control and
image processing.
Cell counting of organotypic slice sections
For quantification, 20 mm sections were chosen that expressed
comparable levels of GFP within the same region of the
dorsolateral telencephalon. For each condition, photographic
images were generated from three separate transfected regions
using a 206 or 406 objective. To quantify the number of
transfected cells that co-labeled with the cell-specific markers, each
digital image was segmented into one-inch horizontal bins. The
total number of cells per bin were recorded by Hoechst (blue
channel) staining, the total transfected cells per bin were recorded
by GFP (green channel) immunostaining, the total number of cells
labeled for the cell-specific markers (PCNA, Tbr2, Tbr1, or NeuN)
per bin were recorded (red channel), and the total transfected cells
which co-labeled with the cell-specific markers (red and green
channel) were recorded and cross-referenced with the Hoechst. To
ensure that cells were within the same plane in the digital images,
each co-labeled cell was confirmed by toggling back and forth
between the blue, red, green, and red-green channels in Adobe
Photoshop. To validate cell counting acquired from 206or 406
images, co-labeled (green/red) cells were visualized at higher
magnification (636) using a Marianas Imaging system and
deconvolution scope.
Statistical Analysis
All data are expressed as the mean6standard error of means
(SEM) from at least three independent experiments (n$3). Pair-
wise comparisons between means were tested by a Student’s t-test,
two-tailed analysis. n.s. not significant; *p,0.05; **p,0.01; and
***p,0.001.
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